The Online Investor
Beam Therapeutics Inc (BEAM)

Beam Therapeutics operates as a biotechnology company. Through its subsidiaries, Co. is a research stage biotechnology company committed to creating a new class of precision genetic medicines, based on Co.'s proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.

BEAM SEC Filing Email Alerts Service
Company Name: 
Beam Therapeutics Inc
Website: 
www.beamtx.com
Sector: 
Biotechnology
Number of ETFs Holding BEAM: 
8
Total Market Value Held by ETFs: 
$13.01M
Total Market Capitalization: 
$1.49B
% of Market Cap. Held by ETFs: 
0.88%
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Beam Therapeutics Inc (BEAM) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.